Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 106 AL 120

Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease?

Ceyzériat K, Tournier BB, Millet P, Frisoni GB, Garibotto V, Zilli T.

J Alzheimers Dis. 2020;74(2):411-419. doi: 10.3233/JAD-190984.

Passive antiamyloid immunotherapy for Alzheimer's disease

Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, de Souza LC.

Curr Opin Psychiatry. 2020 May;33(3):284-291. doi: 10.1097/YCO.0000000000000587.

If Scotland can, why not England?

Benison L.

Br J Community Nurs. 2020 Feb 2;25(2):57. doi: 10.12968/bjcn.2020.25.2.57.

US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development

Morant AV, Vestergaard HT, Lassen AB, Navikas V.

Clin Transl Sci. 2020 Jul;13(4):652-664. doi: 10.1111/cts.12755. Epub 2020 Mar 3.

Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease

Hashemiaghdam A, Mroczek M.

J Neuroimmunol. 2020 Apr 15;341:577185. doi: 10.1016/j.jneuroim.2020.577185. Epub 2020 Feb 3.

Biological subtypes of Alzheimer disease: A systematic review and meta-analysis

Ferreira D, Nordberg A, Westman E.

Neurology. 2020 Mar 10;94(10):436-448. doi: 10.1212/WNL.0000000000009058. Epub 2020 Feb 11.

Alzheimer's disease: targeting the glutamatergic system

Conway ME.

Biogerontology. 2020 Jun;21(3):257-274. doi: 10.1007/s10522-020-09860-4. Epub 2020 Feb 11.

Is Alzheimer's disease a polymicrobial host microbiome dysbiosis?

Singhrao SK, Harding A.

Expert Rev Anti Infect Ther. 2020 Apr;18(4):275-277. doi: 10.1080/14787210.2020.1729741. Epub 2020 Feb 19.

Microglia in Alzheimer's Disease

Süß P, Schlachetzki JCM.

Curr Alzheimer Res. 2020;17(1):29-43. doi: 10.2174/1567205017666200212155234.

Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease

Caffino L, Mottarlini F, Fumagalli F.

CNS Drugs. 2020 Mar;34(3):281-297. doi: 10.1007/s40263-020-00705-9.

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

Shi J, Wei M, Ni J, Sun F, Sun L, Wang J, Yu T, Wang K, Lv P, Wang Y, Zhang Y, Gao X, Gao X, Luo B, Mao S, Zhang B, Ren X, Yu F, Hu W, Yin P, Wu N, Liu X, Bi Q, Wang Y, Tian J; CHASE Study Group.

J Transl Med. 2020 Feb 13;18(1):76. doi: 10.1186/s12967-020-02232-z.

Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer's Disease

Chen WN, Yeong KY.

CNS Neurol Disord Drug Targets. 2020;19(2):85-93. doi: 10.2174/1871527319666200214104331.

Self-calibrated brain network estimation and joint non-convex multi-task learning for identification of early Alzheimer's disease

Lei B, Cheng N, Frangi AF, Tan EL, Cao J, Yang P, Elazab A, Du J, Xu Y, Wang T.

Med Image Anal. 2020 Apr;61:101652. doi: 10.1016/j.media.2020.101652. Epub 2020 Jan 17.

Cyclical amyloid beta-astrocyte activity induces oxidative stress in Alzheimer's disease

Elangovan S, Holsinger RMD.

Biochimie. 2020 Apr-May;171-172:38-42. doi: 10.1016/j.biochi.2020.02.003. Epub 2020 Feb 13.

A Protective Role of Translocator Protein in Alzheimer's Disease Brain

Jung ME.

Curr Alzheimer Res. 2020;17(1):3-15. doi: 10.2174/1567205017666200217105950.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias